Dihydroartemisinin is widely used as an intermediate in the preparation of other artemisinin-derived antimalarial drugs, is recommended as the first-line anti-malarial drug with low toxicity. Dihydroartemisinin possesses promising anticancer activities and induce cancer cell death through apoptotic pathways.

Phosphopeptide; binds to the src SH2 domain.

2''-O-Rhamnosylicariside II is beneficial for improving postmenopausal osteoporosis. It shows potent antioxidant activity, with IC50 values of 90.5 uM.